
Synopsys (SNPS) Stock Forecast & Price Target
Synopsys (SNPS) Analyst Ratings
Bulls say
Synopsys is supported by its leadership in EDA and semiconductor IP, where secular chip complexity, AI/ML adoption, and systems companies bringing design in-house are expanding the customer base and deepening demand for its full-flow tools. Its Investor Day highlighted accelerating EDA/IP growth, an updated FY27 revenue outlook of about $11.15 billion, non-GAAP operating margin guidance of roughly 44%, and FY27 free cash flow of $3.1 billion, while management also raised long-term targets toward mid-teens revenue growth and about 50% operating margin by FY30. The outlook is further strengthened by a recurring, low-cyclicality business model, higher-margin royalty streams in Factory 2, AI monetization with OpenAI and other partners, and roughly $1 billion in planned share repurchases over the coming months.
Bears say
Synopsys is facing a more fragile competitive moat because GPT-Synopsys gives OpenAI control of both the model and harness layers, raising the risk of vendor lock-in, higher inference latency, and eventual vertical integration by frontier labs into EDA tools. The thesis is further weakened by the possibility that domain knowledge diffuses into generic and open-source models over time, eroding the advantage of specialized EDA AI and pressuring Synopsys’ ability to defend pricing and differentiation. On top of that, market share losses in digital and IP, Intel’s 12% share of FY20 (Oct) revenues, software security go-to-market friction, and exposure to execution, regulation, taxes, and information-security risks could all weigh on revenue, earnings, and multiples.
This aggregate rating is based on analysts' research of Synopsys and is not a guaranteed prediction by Public.com or investment advice.
Synopsys (SNPS) Analyst Forecast & Price Prediction
Start investing in Synopsys (SNPS)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Synopsys (SNPS) Forecast
Synopsys (SNPS) Analyst Forecast & Price Prediction
Start investing in Synopsys (SNPS)
Order type
Buy in
Order amount
Est. shares
0 shares